Annual Compliance Report Graphic.

2023 Annual Compliance Report Available

Each year, BWXT Medical submits a comprehensive Annual Compliance Report (ACR) to the Canadian Nuclear Safety Commission (CNSC) for its Kanata facility. The purpose of the ACR is to demonstrate that BWXT Medical has successfully met the requirements of the Nuclear Safety and Control Act and its Class IB Nuclear Substance Processing Facility Operating Licence. The ACR is used by the CNSC to assist in the development of its Regulatory Oversight Report on the performance of Canada’s uranium and nuclear substance processing facilities. Additionally, a public meeting is held to review the Regulatory Oversight Report’s findings at the end of the year. The 2023 ACR is available here.


For any questions about our 2023 Annual Compliance Report, please contact [email protected] or 1.833.657.4565.

Key Contacts:

Community Inquiries:
Phone: 1.833.657.4565
email: [email protected]

Job Seekers:
Please visit www.bwxt.com/careers for current opportunities.

For urgent media inquiries, please contact:
Monifa Miller
Senior Director, Corporate Affairs
+1 519.242.8071
[email protected]

More BWXT Medical News

BWXT Names Vittorio Puppo President of Medical Business

KANATA, Ontario- BWX Technologies, Inc. (NYSE: BWXT) has appointed Vittorio Puppo …

BWXT Medical and NorthStar Medical Radioisotopes Sign Supply Agreement Supporting Actinium-225 Production

• Multi-year supply agreement for radium-226 processing and purification• Collaboration …

BWXT Medical Submits Drug Master File for Actinium-225 API to U.S. Food and Drug Administration

(OTTAWA, Ontario – June 7, 2024) – BWXT Medical Ltd. …

This Website Uses Cookies.

We use cookies to give you the best user experience. No personal information is collected in this process.